Xu Y, Ji H, Zhang Y, Xiong L, et al. Combination of EGFR-TKI and Chemotherapy Versus EGFR-TKI Monotherapy as Neoadjuvant Treatment of Stage III-N2 EGFR-Mutant Non-Small Cell Lung Cancer. Oncologist 2024 Mar 25:oyae052. doi: 10.1093.
PMID: 38529688